The expiry of 24 million deep-out-of-the-money options is a routine non-event with no cash or dilution effect. Monitor upcoming option expiries (e.g., 79.4 million RADO options expiring November 30, 2026) for potential dilution if exercised.
Price Chart
Executive Summary
Radiopharm Theranostics filed a 6-K reporting the expiry of 24 million unlisted options held by director Riccardo Canevari, which lapsed unexercised on September 30, 2026. The cessation reduces potential future dilution by 24 million shares but has no immediate financial impact as no consideration was paid.
Key Facts
- 24,000,000 unlisted options held by director Riccardo Canevari expired unexercised on September 30, 2026
- Options had an exercise price of $0.06 per share
- No consideration was paid by the company for the cessation
- Director's total option holdings decreased from 187,301,188 to 163,301,188
- Total ordinary shares outstanding remain at 4,710,882,790
Financial Impact
No financial impact — options expired worthless with no cash consideration
Risk Factors
- No material risks identified from this filing
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-105456 |
| Document: ea030731701ex99-1.htm | 0001213900-26-105456 |
| Document: ea0307317-6k_radiopharm.htm | 0001213900-26-105456 |
| Document: 0001213900-26-105456-index-headers.html | 0001213900-26-105456 |
| Document: 0001213900-26-105456-index.html | 0001213900-26-105456 |
| Document: 0001213900-26-105456.txt | 0001213900-26-105456 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | — | awaiting T+5 | — | — |
Oct 20, 2026 6d ago | 6-K | $0.9900 | awaiting T+5 | — | $1.01 (+2.02%) |
Oct 14, 2026 11d ago | SC 13G | $1.08 $0.9500 | ▼ −12.04% | ▼ −11.02% | $1.01 (−6.48%) |
Oct 5, 2026 21d ago | 6-K | $1.27 $1.11 | ▼ −12.60% | ▼ −13.02% | $1.01 (−20.47%) |
Oct 1, 2026 25d ago | 6-K | $1.48 $1.11 | ▼ −25.00% | ▼ −26.30% | $1.01 (−31.76%) |
Sep 30, 2026 26d ago | 6-K | $1.62 $1.15 | ▼ −29.01% | ▼ −30.93% | $1.01 (−37.65%) |
Sep 24, 2026 4w ago | EFFECT | $1.57 $1.48 | ▲ +5.85% | ▲ +5.43% | $1.01 (+35.75%) |
Sep 22, 2026 4w ago | 6-K | $1.65 $1.52 | ▼ −7.88% | ▼ −6.69% | $1.01 (−38.79%) |
Sep 14, 2026 6w ago | 6-K | $2.01 $1.61 | ▼ −19.90% | ▼ −20.01% | $1.01 (−49.75%) |
Sep 11, 2026 6w ago | 6-K | $1.98 $1.65 | ▼ −16.67% | ▼ −16.45% | $1.01 (−48.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers